Nmr Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 09-11-2024
- Paid Up Capital ₹ 1.28 M
as on 09-11-2024
- Company Age 33 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -24.25%
(FY 2023)
- Profit -57.95%
(FY 2023)
- Ebitda -28.84%
(FY 2023)
- Net Worth 1.16%
(FY 2023)
- Total Assets 4.37%
(FY 2023)
About Nmr Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.28 M, as per Ministry of Corporate Affairs (MCA) records.
Nagaraj Tanksali, Ashok Kalamdani, Ravindra Kalghatgi, and Fourteen other members serve as directors at the Company.
- CIN/LLPIN
U85110KA1991PTC012280
- Company No.
012280
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 1991
- Date of AGM
26 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dharwad, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nmr Diagnostics?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suhas Kalghatgi  | Managing Director | 11-Jun-2015 | Current |
| Ravindra Kalghatgi | Managing Director | 31-Mar-1993 | Current |
Board Members(15)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sameer Belvi | Director | 26-Sep-2020 | Current |
| Vijaymahantesh Pujari | Director | 25-Sep-2021 | Current |
| Ashok Kalamdani | Director | 31-Mar-1993 | Current |
| Nagaraj Tanksali | Director | 12-Apr-2018 | Current |
| Vinay Gore | Director | 31-Mar-1993 | Current |
| Suryakant Dugani | Director | 30-Jun-1993 | Current |
Financial Performance and Corporate Structure Insights of Nmr Diagnostics.
Nmr Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.25% decrease. The company also saw a substantial fall in profitability, with a 57.95% decrease in profit. The company's net worth moved up by a moderate rise of 1.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nmr Diagnostics?
In 2023, Nmr Diagnostics had a public holding of 38.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nmr Medical Institute Private LimitedActive 34 years 4 monthsNagaraj Tanksali, Ashok Kalamdani and 8 more are mutual person
- Logicare Health Solutions Private LimitedActive 18 years 9 months
Nagaraj Tanksali is a mutual person
- Nmr Imaging Private LimitedActive 26 years 10 months
Ashok Kalamdani, Ravindra Kalghatgi and 7 more are mutual person
- Kshema Orthopaedics Hospitals Private LimitedActive 33 years 5 months
Ashok Kalamdani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nmr Diagnostics?
Nmr Diagnostics has a workforce of 4 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nmr Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nmr Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
